These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Beta blockers and the central nervous system. Schoenen J Cephalalgia; 1986; 6 Suppl 5():47-54. PubMed ID: 2879632 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism of action of drugs currently used in the prevention of migraine]. Fanchamps A Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325 [TBL] [Abstract][Full Text] [Related]
11. [Managing the attacks, preventing headache. Migraine therapy in 2002]. Göbel H; Heinze A; Heinze-Kuhn K MMW Fortschr Med; 2002 May; Suppl 2():43-50. PubMed ID: 12070849 [TBL] [Abstract][Full Text] [Related]
12. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ; Schalekamp MA Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [TBL] [Abstract][Full Text] [Related]
13. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion]. Koebe P; Rost R; Reinke A; Nagel N; Merten U Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic and prophylactic treatment of migraine: a critical reappraisal. Deleu D; Hanssens Y; Worthing EA Clin Neuropharmacol; 1998; 21(5):267-79. PubMed ID: 9789706 [TBL] [Abstract][Full Text] [Related]